| Serial Number | 98377390 |
| Word Mark | ADVANCED MEDICINE PARTNERS |
| Filing Date | Friday, January 26, 2024 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Wednesday, April 2, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organism in the manufacturing process; custom manufacture for others of products relating to biotechnology, namely, recombinant proteins for use in the biotechnology industries; custom manufacture for others of cell therapy products; custom manufacture for others of gene therapy products; custom manufacture of pharmaceuticals in accordance with specific standards GMP regulations |
| Description of Mark | The mark consists of a design suggestive of a vertically oriented chromosome with an electrical bolt forming the junction between the two halves and the words ADVANCED MEDICINE PARTNERS arranged in descending order immediately to the right of the design. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | MEDICINE |
| Goods and Services | Contract development and manufacturing organization (CDMO) services, namely, pharmaceutical drug development services; consulting and advisory services in the field of analytical development and quality control testing of pharmaceutical, gene therapy, and cell therapy products; consulting and advisory services in the field of manufacturing process development for pharmaceutical, gene therapy and cell therapy products; consulting in the field of chemistry manufacturing and controls (CMC) activities; testing of pharmaceutical, gene therapy, and cell therapy products and materials; quality control testing of pharmaceutical products and materials, namely, biopharmaceutical products and materials in accordance with specifications or requirements of regulatory standards applicable in target countries; testing and validation services of biopharmaceutical products to assure compliance with global regulatory requirements, specifications, and industry standards for pharmaceutical, cell therapy and gene therapy methods of development; technical consulting for regulatory compliance in the field of chemistry manufacturing and controls (CMC) |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | Monday, October 2, 2023 |
| First Use In Commerce Date | Monday, October 2, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, October 2, 2023 |
| First Use In Commerce Date | Monday, October 2, 2023 |
| Party Name | JAGUAR GENE THERAPY, LLC |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | LAKE FOREST, IL 60045 |
| Party Name | Advanced Medicine Partners, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lake Forest, IL 60045 |
| Event Date | Event Description |
| Friday, January 26, 2024 | NEW APPLICATION ENTERED |
| Monday, July 29, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, July 29, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 12, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, August 20, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 20, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 20, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, November 15, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, November 15, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, February 5, 2025 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, February 20, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 20, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 20, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 2, 2025 | FINAL REFUSAL WRITTEN |
| Wednesday, April 2, 2025 | FINAL REFUSAL E-MAILED |
| Wednesday, April 2, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, April 2, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, April 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |